Journament

Keyword Connections - tumor cells Keywords

Connection Type	Connection
Journals	No Journal Connected
Research Groups	No Research Group Connected
Bibliographies	[1] Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus [2] Tumor induction of VEGF promoter activity in stromal cells [3] Recombinant superoxide dismutase (SOD) administered by aerosol inhibits respiratory syncytial virus infection in cotton rats [4] Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes [5] Antiviral properties of extract of Opuntia streptacantha [6] Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse [7] In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses [8] Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome [9] Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides [10] Evaluation of the antiviral activity of N-(phosphonoacetyl)-L-aspartate against paramyxoviruses in tissue culture and against respiratory syncytial virus in cotton rats [11] CBP-induced stimulation of c-Fos activity is abrogated by E1A [12] Association of the APC gene product with beta-catenin [13] Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2 [14] Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes [15] Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells [16] Genetic analysis of chemoresistance in primary murine lymphomas [17] Regulation of p53 stability by Mdm2 [18] Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers [19] Mdm2 promotes the rapid degradation of p53 [20] Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity [21] On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database [22] Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1) [23] Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential [24] 1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity [25] Correction to: High-Resolution Adhesion Kinetics of EGCG-Exposed Tumor Cells on Biomimetic Interfaces: Comparative Monitoring of Cell Viability Using Label-Free Biosensor and Classic End-Point Assays (ACS Omega (2018) 3:4 (3882?3891) DOI: 10.1021/acsomega.7b01902) [26] Erratum: Editor's note: Toll-like receptors on tumor cells facilitate evasion of immune surveillance (Cancer Research (2005) 65 (5009–5014)) [27] Whole Genome Sequencing of Single Circulating Tumor Cells Isolated by Applying a Pulsed Laser to Cell-Capturing Microstructures. [28] Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells. [29] A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy. [30] Rapid prototyping of Nanoroughened polydimethylsiloxane surfaces for the enhancement of immunomagnetic isolation and recovery of rare tumor cells [31] Receptor-Meditated Endocytosis by Hyaluronic Acid@Superparamagnetic Nanovetor for Targeting of CD44-Overexpressing Tumor Cells [32] Circulating tumor cells before and during follow-up after breast cancer surgery. [33] Targeting tumor cells and neovascularization using RGD-functionalized magnetoliposomes. [34] Chemiluminescent liposomes as a theranostic carrier for detection of tumor cells under oxidative stress. [35] Ibrutinib potentiates anti-hepatocarcinogenic efficacy of sorafenib by targeting EGFR in tumor cells and BTK in immune cells in the stroma. [36] Anti-Tumor Drug-Loaded Oxygen Nanobubbles for the Degradation of HIF-1α and the Upregulation of Reactive Oxygen Species in Tumor Cells. [37] Nuclear factor-kappaB mediates up-regulation of cathepsin B by doxorubicin in tumor cells. [38] A 2-compartment bone tumor model to investigate interactions between healthy and tumor cells. [39] Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system. [40] The viable circulating tumor cells with cancer stem cells feature, where is the way out? [41] A method for detecting tumor cells derived from colorectal cancer by targeting cell surface glycosylation with affinity capillary electrophoresis. [42] Dormant tumor cells interact with memory CD8 T cells in RET transgenic mouse melanoma model. [43] Magnetic Temperature-Sensitive Solid-Lipid Particles for Targeting and Killing Tumor Cells. [44] Comparative Analysis of Blood and Bone Marrow for the Detection of Circulating and Disseminated Tumor Cells and Their Prognostic and Predictive Value in Esophageal Cancer Patients [45] Clinical significance of isolated tumor cells and micrometastasis in low-grade, stage I endometrial cancer [46] antitumor cell-complex vaccines employing genetically modified tumor cells and fibroblasts [47] clinical relevance of circulating tumor cells in esophageal cancer detected by a combined macs enrichment method [48] efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus [49] polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of tap73 [50] a genetically modified attenuated listeria vaccine expressing hpv16 e7 kill tumor cells in direct and antigen-specific manner [51] aminodi(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, effects in human tumor cells growth, cell cycle analysis, apoptosis and evaluation of toxicity using non-tumor cells [52] function of mir-146a-5p in tumor cells as a regulatory switch between cell death and angiogenesis: macrophage therapy revisited [53] uroplakin ib gene transcription in urothelial tumor cells is regulated by cpg methylation [54] proteolytic activity of human lymphoid tumor cells.correlation with tumor progression [55] rgd peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells [56] isolation and characterization of circulating tumor cells in prostate cancer [57] automated classification of circulating tumor cells and the impact of interobsever variability on classifier training and performance [58] significance of circulating tumor cells in soft tissue sarcoma [59] rolling in the deep: therapeutic targeting of circulating tumor cells [60] case report: iatrogenic seeding of tumor cells in thigh soft tissue upon surgical removal of intracranial meningioma [61] excessive levels of diverse phytoestrogens can modulate steroidogenesis and cell migration of kgn human granulosa-derived tumor cells [62] "sea anemone-like ciliated tumor cells" in a case of serous cystadenocarcinoma of the ovary [63] etumortype, an algorithm of discriminating cancer types for circulating tumor cells or cell-free dnas in blood [64] rat prostate tumor cells progress in the bone microenvironment to a highly aggressive phenotype [65] oncogenic kras desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation [66] pod-1/tcf21 reduces shp expression, affecting lrh-1 regulation and cell cycle balance in adrenocortical and hepatocarcinoma tumor cells [67] magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with gd-loaded low-density lipoprotein particles [68] time-dependent prognostic impact of circulating tumor cells detection in non-metastatic breast cancer: 70-month analysis of the remagus02 study [69] human cytomegalovirus infection of tumor cells downregulates ncam (cd56): a novel mechanism for virus-induced tumor invasiveness' [70] matricryptins network with matricellular receptors at the surface of endothelial and tumor cells [71] dysregulated expression of glycolipids in tumor cells: from negative modulator of anti-tumor immunity to promising targets for developing therapeutic agents [72] how do cd4+ t cells detect and eliminate tumor cells that either lack or express mhc class ii molecules? [73] an aqueous extract of tuberaria lignosa inhibits cell growth, alters the cell cycle profile, and induces apoptosis of nci-h460 tumor cells [74] stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer [75] expression of cathepsin l in tumor cells and tumor-associated macrophages in patients with ewing sarcoma family of tumors: a pilot study [76] the potential for circulating tumor cells in pancreatic cancer management [77] dynamic fluctuation of circulating tumor cells during cancer progression [78] 778 Nonfibrillar and fibrillar amyloid in cultures of tumor cells [79] PILRα on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunity.